Skip to main content
. 2023 Nov 21;13:1219071. doi: 10.3389/fonc.2023.1219071

Figure 1.

Figure 1

Flow chart of the study’s population with inclusion and exclusion criteria. BC, breast cancer; HEBC, human epidermal growth factor receptor 2 enriched BC. TNBC, triple-negative breast cancer. “n=466” represented the total lesion number.